Results 121 to 130 of about 121,877 (300)
Severe Xanthogranulomatous prostatitis mimicking prostate cancer: a case report
Background Xanthogranulomatous prostatitis is a rare, noncancerous inflammatory condition of the prostate that clinically resembles prostatic carcinoma, necessitating a pathological examination for accurate diagnosis.
Wael Abdo Hassan +3 more
doaj +1 more source
NEOVASCULARIZATION IN PROSTATIC ADENOCARCINOMA AS DETERMINED BY CD34: A RETROSPECTIVE STUDY
Background: Microvessel density is one of the variables that are thought to affect the natural history of prostatic carcinoma in as much as its degree influences tumor progression including the ability of invasion and metastasis.
Usama T Al-Badri +2 more
doaj +4 more sources
Noncoding-RNA-Based Therapeutics with an Emphasis on Prostatic Carcinoma-Progress and Challenges. [PDF]
Nava VE, Perera PY, Kumar N, Jain M.
europepmc +1 more source
The FAK‐STAT3‐NNMT axis drives anoikis resistance in circulating tumor cells by reprogramming fatty acid oxidation. Targeting this metabolic vulnerability suppresses metastasis, untangling a key mechanism of breast cancer progression and revealing NNMT as a promising therapeutic target.
Qingchao Tong +13 more
wiley +1 more source
This review surveys nanoparticle‐based strategies to enhance adoptive cell therapy, particularly CAR‐T cell approaches, in solid tumor treatment. It describes how nanoparticles can improve tumor immunogenicity and T‐cell infiltration while reducing toxicity, and how they enable in vivo CAR‐T cell generation.
Erica Frostegård +19 more
wiley +1 more source
Second-harmonic generation microscopy analysis reveals proteoglycan decorin is necessary for proper collagen organization in prostate. [PDF]
Collagen remodeling occurs in many prostate pathologies; however, the underlying structural architecture in both normal and diseased prostatic tissues is largely unexplored.
Bushman, Wade A. +5 more
core +1 more source
Cystic Prostatic Carcinoma - A Clinical Case and Literature Review. [PDF]
Popov SV +3 more
europepmc +1 more source
Prostate cancer remains a leading cause of male cancer death, yet screening cannot reliably identify aggressive disease, underscoring the need for tissue biomarkers. It is shown that primary tumors increase ER–plasma membrane junction signaling via STIM1/ORP5, whereas metastasis features their loss, Golgi dispersal, and rapid conversion of high‐mannose
Amanda J. Macke +14 more
wiley +1 more source

